|

Neoadjuvant Chemotherapy Combined with Immunotherapy Clinical Trials

2 actively recruiting trials

▲ +1 trial since June 2026

Pipeline

Phase 2: 2

Top Sponsors

  • Obstetrics & Gynecology Hospital of Fudan University1
  • Cancer Institute and Hospital, Chinese Academy of Medical Sciences1

Indications

Other2 trials

Evaluate the Efficacy and Safety of Adebrelimab Combined With Chemotherapy With or Without Radiotherapy as Neoadjuvant Treatment for HER2-Negative Locally Advanced Breast Cancer
Phase 2
Ivonescimab Combined With Paclitaxel and Cisplatin as Neoadjuvant Therapy Followed by Type A Hysterectomy in Stage IB2 and IIA1 Cervical Cancer
Phase 2

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.